Patent Assignment
Reel/Frame 028385/0371
Release of Security Interest
Recorded: 2012-06-15
Pages: 13
Assignors
THOMAS, MCNERNEY & PARTNERS II, L.P.
Executed: 2012-06-15
TMP NOMINEE II, LLC
Executed: 2012-06-15
TMP ASSOCIATES II, L.P.
Executed: 2012-06-15
DOMAIN PARTNERS VI, L.P.
Executed: 2012-06-15
VENTURES WEST 7 LIMITED PARTNERSHIP
Executed: 2012-06-15
VENTURES WEST 7 U.S. LIMITED PARTNERSHIP
Executed: 2012-06-15
WORKING OPPORTUNITY FUND (EVCC) LTD.
Executed: 2012-06-15
BDC CAPITAL INC.
Executed: 2012-06-15
QUAKER BIOVENTURES, L.P.
Executed: 2012-06-15
GARDEN STATE LIFE SCIENCES VENTURE FUND, L.P.
Executed: 2012-06-15
Assignee
CELATOR PHARMACEUTICALS, INC.
303 B COLLEGE ROAD, PRINCETON, NEW JERSEY, 08540
Covered Properties
(19)
Liposome Loading with Metal Ions
Lipid Carrier Compositions with Enhanced Blood Stability
Compositions for Delivery of Drug Combinations
Compositions for Delivery of Drug Combinations
Compositions for delivery of drug combinations
Application:
11/304,328 →
Publication:
US 2006/0165771
Fixed Ratio Drug Combination Treatments for Solid Tumors
Liposomal Formulations of Anthracycline Agents and Cytidine Analogs
Particulate Constructs For Release of Active Agents
Application:
11/632,884 →
Publication:
US 2008/0299205
Compositions for delivery of drug combinations
Application:
11/701,326 →
Publication:
US 2007/0148255
Compositions for Delivery of Drug Combinations
Application:
11/841,786 →
Publication:
US 2008/0075762
Liposome Loading with Metal Ions
Fixed Drug Ratios for Treatment of Hematopoietic Cancers and Proliferative Disorders
Localized Delivery of Drug Combinations
Application:
12/095,494 →
Publication:
US 2009/0304766
Fixed Drug Ratios for Treatment of Hematopoietic Cancers and Proliferative Disorders
Application:
12/526,930 →
Publication:
US 2010/0303895
Fixed Ratio Camptothecens/Platinum Agents
Application:
12/673,157 →
Publication:
US 2012/0003294
Taxane Delivery System
Lipid Carrier Compositions with Enhanced Blood Stability
Application:
12/884,098 →
Publication:
US 2011/0002982
Combination Methods and Compositions
Application:
13/122,454 →
Publication:
US 2011/0223241
Liposomal Formulations of Anthracycline Agents and Cytidine Analogs
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Jul 12, 2016
From: CELATOR PHARMACEUTICALS, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 039312/0397 →
Release of Security Interest
May 5, 2021
From: BANK OF AMERICA, N.A.
To: JAZZ PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED
Reel/Frame 056150/0708 →
Security Agreement
May 5, 2021
From: CAVION, INC.; CELATOR PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 056151/0010 →
Change of Name
Aug 7, 2025
From: CELATOR PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Reel/Frame 072341/0137 →
Corrective Assignment to Correct the Removal of 8 Property Numbers Previously Recorded at Reel: 072341 Frame: 0137. Assignor(S) Hereby Confirms the Change of Name.
Oct 8, 2025
From: CELATOR PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Reel/Frame 073058/0985 →
Corrective Assignment to Correct the Remove 2 Application Numbers Previously Recorded at Reel: 07234 Frame: 0137. Assignor(S) Hereby Confirms the Change of Name.
Oct 9, 2025
From: CELATOR PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Reel/Frame 073133/0142 →